Insider Buying: Myomo (NYSEAMERICAN:MYO) Director Buys $14,000.00 in Stock

Myomo, Inc. (NYSEAMERICAN:MYO) Director Heather Getz acquired 20,000 shares of Myomo stock in a transaction dated Monday, March 16th. The stock was purchased at an average price of $0.70 per share, for a total transaction of $14,000.00. Following the completion of the acquisition, the director directly owned 131,754 shares in the company, valued at approximately $92,227.80. This represents a 17.90% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Myomo Stock Performance

NYSEAMERICAN:MYO opened at $0.72 on Friday. The firm has a market capitalization of $27.77 million, a PE ratio of -1.95 and a beta of 1.17. The company has a debt-to-equity ratio of 0.98, a current ratio of 3.30 and a quick ratio of 2.93. The business’s fifty day moving average price is $0.82 and its 200 day moving average price is $0.91. Myomo, Inc. has a 12 month low of $0.63 and a 12 month high of $5.62.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on MYO. Ascendiant Capital Markets reduced their price objective on shares of Myomo from $10.50 to $10.00 and set a “buy” rating for the company in a research report on Friday, November 21st. Craig Hallum reiterated a “buy” rating on shares of Myomo in a research note on Tuesday, March 10th. Four investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, Myomo currently has a consensus rating of “Buy” and a consensus target price of $7.67.

Institutional Investors Weigh In On Myomo

Several large investors have recently modified their holdings of the company. Dynamic Technology Lab Private Ltd purchased a new position in shares of Myomo during the first quarter worth approximately $75,000. Invesco Ltd. purchased a new stake in Myomo in the 2nd quarter valued at $37,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in Myomo in the 2nd quarter valued at $38,000. Intech Investment Management LLC acquired a new stake in Myomo during the 2nd quarter worth $38,000. Finally, Acadian Asset Management LLC purchased a new position in Myomo during the 1st quarter worth $114,000. 44.99% of the stock is owned by institutional investors and hedge funds.

About Myomo

Myomo, Inc (NYSE American: MYO) is a medical robotics company specializing in developing and commercializing powered orthotic devices designed to restore mobility and function for individuals with upper-limb weakness. The company’s flagship product, the MyoPro®, is an FDA-cleared, wearable robotic orthosis that leverages proprietary sensors and actuators to detect and amplify users’ own muscle signals, enabling patients with conditions such as stroke, spinal cord injury, muscular dystrophy and other neuromuscular disorders to perform daily activities with greater independence.

Myomo markets the MyoPro through a network of licensed orthotic and prosthetic professionals, clinics and hospitals across North America.